Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	15.60	19.92	17.23
Graham Fair Price	0.00	0.00	0.00
PEG	0.00	0.00	0.00
Price/Book	0.00	0.00	0.00
Price/Cash Flow	0.00	0.00	0.00
Prices/Earnings	0.00	0.00	0.00
Price/Sales	0.00	0.00	0.00
Price/FCF	0.00	0.00	0.00
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.71	0.71
Operating Margin	0.00	0.14	0.14
ROA	47.55	0.02	0.01
ROE	0.02	0.02	49.63
ROIC	< 0.005	< 0.005	39.48
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	< 0.005	-29.52
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.02	0.00	inf
EPS QOQ	-1.00	0.00	inf
FCF QOQ	0.00	0.00	0.00
Revenue QOQ	1.14	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-3217.70	-100.00
Days Sales Outstanding (DSO)	402.11	402.11	0.00
Inventory Turnover	0.00	-0.03	-100.00
Debt/Capitalization	0.15	0.20	39.49
Quick Ratio	0.74	2.01	170.30
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.00	0.00	0.00
Cash	0.00	0.00	0.00
Capex	0.00	0.00	0.00
Free Cash Flow	0.00	0.00	0.00
Revenue	0.00	0.00	0.00
Naive Interpretation	member

05 - Per Share Metrics · Not Interpreted

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	4.60	9.41	104.57
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.23	19.92	15.60
Naive Interpretation	Member

06 - Financial Health · Bad

Rating